Yaxiong Sang

1.2k total citations
22 papers, 660 citations indexed

About

Yaxiong Sang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Yaxiong Sang has authored 22 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Yaxiong Sang's work include Immune cells in cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immunotherapy and Immune Responses (3 papers). Yaxiong Sang is often cited by papers focused on Immune cells in cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immunotherapy and Immune Responses (3 papers). Yaxiong Sang collaborates with scholars based in China, Canada and Ethiopia. Yaxiong Sang's co-authors include Xuelei Ma, Guobo Shen, Fengtian Wang, Wen Nie, Lei Liu, Xiang Gao, Yu Jiang, Wuning Zhong, Jing Zhang and Chi Shu and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yaxiong Sang

22 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaxiong Sang China 16 291 278 145 122 95 22 660
Eric Lipp United States 19 246 0.8× 264 0.9× 102 0.7× 152 1.2× 186 2.0× 85 940
Niya Xiong United States 12 305 1.0× 256 0.9× 68 0.5× 125 1.0× 75 0.8× 37 693
Claire Henry New Zealand 16 347 1.2× 150 0.5× 71 0.5× 102 0.8× 100 1.1× 58 807
Partha Mukhopadhyay India 13 337 1.2× 171 0.6× 107 0.7× 86 0.7× 62 0.7× 41 618
Yunyan Sun China 14 323 1.1× 124 0.4× 103 0.7× 122 1.0× 53 0.6× 32 546
Daniela Luvero Italy 21 288 1.0× 261 0.9× 102 0.7× 185 1.5× 89 0.9× 66 1.4k
Hussein A. Abbas United States 18 524 1.8× 279 1.0× 141 1.0× 160 1.3× 47 0.5× 79 1.1k
Hadi Shojaei Iran 13 197 0.7× 143 0.5× 99 0.7× 97 0.8× 60 0.6× 36 798
Fangrong Shen China 17 346 1.2× 163 0.6× 127 0.9× 260 2.1× 57 0.6× 45 783
Thomas W. Jobling Australia 18 214 0.7× 182 0.7× 112 0.8× 79 0.6× 59 0.6× 40 929

Countries citing papers authored by Yaxiong Sang

Since Specialization
Citations

This map shows the geographic impact of Yaxiong Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxiong Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxiong Sang more than expected).

Fields of papers citing papers by Yaxiong Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaxiong Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxiong Sang. The network helps show where Yaxiong Sang may publish in the future.

Co-authorship network of co-authors of Yaxiong Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaxiong Sang. A scholar is included among the top collaborators of Yaxiong Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaxiong Sang. Yaxiong Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haiyue, Leina Sun, Yaxiong Sang, et al.. (2019). A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy. Lung Cancer. 130. 135–142. 17 indexed citations
2.
Feng, Qin, Yaxiong Sang, Jie Zhang, et al.. (2018). A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients. Cancer Management and Research. Volume 10. 115–121. 18 indexed citations
3.
He, Zhiyao, Xiawei Wei, Cuicui Ma, et al.. (2016). Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex. Scientific Reports. 6(1). 23764–23764. 33 indexed citations
4.
Fan, Chuanwen, Ran Lu, Bin Shao, et al.. (2016). Forced co-expression of IL-21 and IL-7 in whole-cell cancer vaccines promotes antitumor immunity. Scientific Reports. 6(1). 32351–32351. 17 indexed citations
5.
Guo, Jun, Yaxiong Sang, Tao Yin, et al.. (2016). miR-1273g-3p participates in acute glucose fluctuation-induced autophagy, dysfunction, and proliferation attenuation in human umbilical vein endothelial cells. American Journal of Physiology-Endocrinology and Metabolism. 310(9). E734–E743. 22 indexed citations
6.
Wen, Feng, Yongmei Liu, Wei Wang, et al.. (2016). Adenomatous polyposis coligenotype-dependent toll-like receptor 4 activity in colon cancer. Oncotarget. 7(7). 7761–7772. 4 indexed citations
7.
Shao, Bin, Xiawei Wei, Min Luo, et al.. (2015). Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis. Scientific Reports. 5(1). 16437–16437. 17 indexed citations
8.
Sang, Yaxiong, Chunju Fang, Bin Shao, et al.. (2015). Immunotherapy of tumors with human telomerase reverse transcriptase immortalized human umbilical vein endothelial cells. International Journal of Oncology. 47(5). 1901–1911. 20 indexed citations
9.
Guo, Fuchun, Xiaoke Liu, Qing Qin, et al.. (2015). EML4-ALK induces epithelial–mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells. Biochemical and Biophysical Research Communications. 459(3). 398–404. 25 indexed citations
10.
Liu, Xiaoke, Yong Xu, Fuchun Guo, et al.. (2015). Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer. Journal of Hematology & Oncology. 8(1). 67–67. 48 indexed citations
11.
Wu, Tianming, Xiang Pu, Jiannan Zhang, et al.. (2014). Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists. Bioorganic & Medicinal Chemistry Letters. 24(5). 1426–1431. 7 indexed citations
12.
Ma, Xuelei, Jing Zhang, Wuning Zhong, et al.. (2014). The diagnostic role of a short screening tool—the distress thermometer: a meta-analysis. Supportive Care in Cancer. 22(7). 1741–1755. 144 indexed citations
13.
Wu, Dongming, Peng Zhang, Yaxiong Sang, et al.. (2014). Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma. FEBS Letters. 588(10). 1921–1929. 57 indexed citations
14.
Li, Yuli, Guobo Shen, Wen Nie, et al.. (2014). Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity. Journal of Cancer Research and Clinical Oncology. 140(11). 1815–1823. 7 indexed citations
15.
Yin, Tao, Sisi He, Xiaoling Liu, et al.. (2014). Extravascular Red Blood Cells and Hemoglobin Promote Tumor Growth and Therapeutic Resistance as Endogenous Danger Signals. The Journal of Immunology. 194(1). 429–437. 30 indexed citations
16.
17.
Zhang, Binglan, Xuelei Ma, Xiang Gao, et al.. (2013). Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer. Journal of Cancer Research and Clinical Oncology. 139(5). 797–807. 11 indexed citations
18.
Gong, Fengming, Xingchen Peng, Can Luo, et al.. (2013). Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma. Molecular Cancer. 12(1). 125–125. 46 indexed citations
19.
Nie, Wen, Xuelei Ma, Yaxiong Sang, et al.. (2012). Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26. Clinical and Experimental Medicine. 14(2). 203–213. 7 indexed citations
20.
Deng, Rui, Shimin Wang, Tao Yin, et al.. (2012). Inhibition of Tumor Growth and Alteration of Associated Macrophage Cell Type by an HO-1 Inhibitor in Breast Carcinoma-Bearing Mice. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(10). 473–482. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Lipp Breakdown of academic impact, for papers by Niya Xiong Breakdown of academic impact, for papers by Claire Henry Breakdown of academic impact, for papers by Partha Mukhopadhyay Breakdown of academic impact, for papers by Yunyan Sun Breakdown of academic impact, for papers by Daniela Luvero Breakdown of academic impact, for papers by Hussein A. Abbas Breakdown of academic impact, for papers by Hadi Shojaei Breakdown of academic impact, for papers by Fangrong Shen Breakdown of academic impact, for papers by Thomas W. Jobling
Rankless by CCL
2026